Acquisition by Pramoda Anita of 12505 shares of Health Catalyst subject to Rule 16b-3
| HCAT Stock | USD 7.01 0.07 0.99% |
Slightly above 61% of Health Catalyst's investor base is looking to short. The analysis of the overall investor sentiment regarding Health Catalyst suggests that many traders are alarmed. Health Catalyst's investing sentiment can be driven by a variety of factors including economic data, Health Catalyst's earnings reports, geopolitical events, and overall market trends.
Health |
Filed transaction by Health Catalyst Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Health Catalyst Fundamental Analysis
We analyze Health Catalyst's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Catalyst using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Catalyst based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Health Catalyst is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Health Catalyst Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Health Catalyst stock to make a market-neutral strategy. Peer analysis of Health Catalyst could also be used in its relative valuation, which is a method of valuing Health Catalyst by comparing valuation metrics with similar companies.
Peers
Health Catalyst Related Equities
| NRC | National Research | 1.32 | ||||
| CERT | Certara | 1.04 | ||||
| FORA | Forian | 0.49 | ||||
| PRVA | Privia Health | 0.41 | ||||
| HSTM | HealthStream | 0.03 | ||||
| SLP | Simulations Plus | 0.18 | ||||
| HQY | HealthEquity | 0.92 | ||||
| EVH | Evolent Health | 1.35 | ||||
| PINC | Premier | 2.75 | ||||
| DH | Definitive Healthcare | 2.84 |
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.